Beijing Beilu Pharmaceutical Co., Ltd. (300016.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Beijing Beilu Pharmaceutical Co., Ltd.
—
Beijing Beilu Pharmaceutical Co., Ltd. is led by CEO Xu Wang, employs 1,188 people, headquartered in Beijing, CN, publicly traded since 2009.
Beijing Beilu Pharmaceutical Co., Ltd. (300016.SZ) stock trades at $8.05 with a market capitalization of $4.74B. The stock is valued at a price-to-earnings (P/E) ratio of 31.35, price-to-book of 1.89, price-to-sales of 3.66. Over the past 52 weeks the stock has ranged between $7.08 and $11.38, and currently trades 29.3% below its 52-week high. It pays a dividend yielding 0.56%.
On profitability, Beijing Beilu Pharmaceutical Co., Ltd. generates a return on equity (ROE) of 6.50%, an operating margin of 14.65%, a net profit margin of 11.01%.
Official website: www.beilu.com.cn
Beijing Beilu Pharmaceutical Co., Ltd. (300016.SZ) — frequently asked questions
What is Beijing Beilu Pharmaceutical Co., Ltd. (300016.SZ) stock price today?
Beijing Beilu Pharmaceutical Co., Ltd. (300016.SZ) is currently trading at $8.05, down 0.74% today.
What is 300016.SZ P/E ratio?
Beijing Beilu Pharmaceutical Co., Ltd.'s P/E ratio is 31.35. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.
What is 300016.SZ return on equity (ROE)?
Beijing Beilu Pharmaceutical Co., Ltd.'s return on equity (ROE) is 6.50%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is Beijing Beilu Pharmaceutical Co., Ltd.'s market cap?
Beijing Beilu Pharmaceutical Co., Ltd. has a market capitalization of $4.74B.
Does 300016.SZ pay a dividend?
Yes. Beijing Beilu Pharmaceutical Co., Ltd. currently yields 0.56%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 300016.SZ carry?
Beijing Beilu Pharmaceutical Co., Ltd. has a debt-to-equity ratio of 0.21. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 300016.SZ's profit margin?
Beijing Beilu Pharmaceutical Co., Ltd. reports a net profit margin of 11.01% — the share of revenue left after every cost, including tax and interest.
What sector is 300016.SZ in?
Beijing Beilu Pharmaceutical Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 300016.SZ listed on?
Beijing Beilu Pharmaceutical Co., Ltd. trades on SHZ under the ticker 300016.SZ.
What is 300016.SZ's 52-week range?
Over the last year Beijing Beilu Pharmaceutical Co., Ltd. has traded between $7.08 and $11.38.
Related — Stocks
Popular Stocks
Screens 300016.SZ currently matches
On the figures above, Beijing Beilu Pharmaceutical Co., Ltd. passes the filters for 7 of our ready-made screens, among them Low Debt Stocks, Stocks Under $10, Stocks Under $100. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.